Alveolar rhabdomyosarcoma has superior response rates to vinorelbine compared to embryonal rhabdomyosarcoma in patients with relapsed/refractory disease: A meta‐analysis

BACKGROUND: Patients with alveolar rhabdomyosarcoma (ARMS) have inferior outcomes compared to patients with embryonal rhabdomyosarcoma (ERMS) and more effective chemotherapy options are needed for these patients. Vinorelbine is a semisynthetic vinca alkaloid that has clinical activity in relapsed rh...

Descripción completa

Detalles Bibliográficos
Autores principales: Allen‐Rhoades, Wendy, Lupo, Philip J., Scheurer, Michael E., Chi, Yueh‐Yun, Kuttesch, John F., Venkatramani, Rajkumar, Meyer, William H., Mascarenhas, Leo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225185/
https://www.ncbi.nlm.nih.gov/pubmed/37016270
http://dx.doi.org/10.1002/cam4.5749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225185/
https://www.ncbi.nlm.nih.gov/pubmed/37016270
http://dx.doi.org/10.1002/cam4.5749

Ejemplares similares